- Home
- / Talis Biomedical
Talis Biomedical
Stock Price
$1.7
2024-10-29
Market Capitalization
$3 M
2024-10-29
Revenue
$2.1 M
FY, 2023
Talis Biomedical Summary
Company Summary
- Overview
- Talis Biomedical is a company specializing in biomedical diagnostics. It aims to develop a diagnostic platform for infectious diseases combining slip chips, fluorescence, and real-time imaging.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- Menlo Park, CA, US | view all locations
- Website
- https://talisbio.com/
- Cybersecurity rating
Table of Contents
Key People
Roger Moody, Chief Financial Officer
Douglas Liu, Senior Vice President, Operations
Rustem Ismagilov, Co-Founder & Director, Advisor
LocationsView all
3 locations detected
Menlo Park, CA HQ
United States
230 Constitution Dr
Chicago, IL
United States
125 S Clark St 17th floor
Chicago, IL
United States
1375 W Fulton Market #700
Talis Biomedical Financials
Summary Financials
- Net income (Q2, 2024)
- ($8.8M)
- Cash (Q2, 2024)
- $59.9M
- EBIT (Q2, 2024)
- ($9.6M)
- Enterprise value
- ($38.0M)